Dr. Ravichandran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7 Clarendon Ct
Holmdel, NJ 07733Phone+1 732-946-0890
Education & Training
Indiana University School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1993 - 1995
Rutgers Health/Jersey City Medical CenterResidency, Internal Medicine, 1990 - 1993
Chingleput Medical CollegeClass of 1987
Certifications & Licensure
NJ State Medical License 1995 - 2025
Publications & Presentations
PubMed
- Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial.Alexa B Kimball, Falk G Bechara, Aysha Badat, Evangelos J Giamarellos-Bourboulis, Alice B Gottlieb
The British Journal of Dermatology. 2025-03-18 - Secukinumab efficacy in patients with hidradenitis suppurativa assessed by the International Hidradenitis Suppurativa Severity Score System (IHS4): A post hoc analysis...Christos C Zouboulis, Athanassios Kyrgidis, Afsaneh Alavi, Gregor B E Jemec, Antonio Martorell
Journal of the European Academy of Dermatology and Venereology. 2024-10-19 - 1 citationsNew insights on hidradenitis suppurativa phenotypes and treatment response: An exploratory automated analysis of the SUNSHINE and SUNRISE trials.Anna Passera, Elisa Muscianisi, David Demanse, Ginette A Okoye, Gregor B E Jemec
Journal of the European Academy of Dermatology and Venereology. 2024-08-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
